AU:EMD Stock Latest News
Company AnnouncementsEmyria Records Sir John Tooke’s Cessation and Nil Securities Interests1d agoEMD
Company AnnouncementsEmyria 2026 Annual General Meeting Presentation1d agoEMD
Company AnnouncementsEmyria Reports Cessation of 21,833,333 EMDAX Options3d agoEMD
Company AnnouncementsEmyria Presentation Provides No Substantive Quarterly Update1w agoEMD
Company AnnouncementsEmyria schedules investor webinar as it pushes ahead in data-driven mental-health innovation2w agoEMD
Company AnnouncementsEmyria signals ambition in global psychedelic treatment push1M agoEMD
Company AnnouncementsEmyria Director Professor Sir John Tooke to Retire as Board Succession Review Begins1M agoEMD
Company AnnouncementsEmyria Taps Former U.S. VA Secretary Shulkin to Bolster U.S. Psychedelic Strategy1M agoEMD- Company AnnouncementsEmyria options lapse as 7.85 million EMDAW securities expire unexercised1M agoEMD
Company AnnouncementsEmyria Ltd Seeks ASX Quotation for Additional Ordinary Shares1M agoEMD
Company AnnouncementsEmyria taps former U.S. VA Secretary Shulkin to drive U.S. psychedelic strategy1M agoEMD
Company AnnouncementsEmyria flags safety risks and regulatory hurdles for experimental psychedelic therapies2M agoEMD
Company AnnouncementsEmyria Doubles Revenue but Posts Wider Annual Loss2M agoEMD
Company AnnouncementsEmyria Sets 2026 AGM Date and Highlights Psychedelic Therapy Risks2M agoEMD
Company AnnouncementsEmyria Moves to Expand Psychedelic Treatment Capacity Ahead of Q42M agoEMD- Company AnnouncementsEmyria Options Lapse, Trimming Potential Share Dilution2M agoEMD
Company AnnouncementsEmyria relocates head office as it advances psychedelic-assisted therapy programs3M agoEMDCompany AnnouncementsEmyria accelerates national Empax rollout as revenues surge and clinical data impress3M agoEMD
Company AnnouncementsEmyria invites investors to quarterly update amid progress in experimental mental health therapies3M agoEMD
